Cosmos Health (COSM) Net Cash Flow (2010 - 2026)
Cosmos Health's (COSM) quarterly Net Cash Flow came in at $185096.0 in Q2 2026, down 60.3% on a YoY basis from $466265.0 in Q2 2025, and up 112.96% quarter-over-quarter from -$1.4 million in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) Net Cash Flow (2010 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Net Cash Flow for 17 consecutive years, with $185096.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Cash Flow fell 60.3% year-over-year to $185096.0; the trailing twelve-month figure through Jun 2026 stood at $1.5 million (up 51.79% YoY), and the FY2025 full-year result was $3.6 million, up 203.6% from the prior year.
- Net Cash Flow advanced to $185096.0 in Q2 2026 per COSM's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $20.3 million in Q4 2022 and bottomed at -$9.9 million in Q2 2023.
- Historically, Net Cash Flow has averaged $129750.0 across 5 years, with a median of -$253645.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow jumped 2817.76% in 2022, then plunged 2529.47% in 2023.
- Over 5 years, Net Cash Flow stood at $20.3 million in 2022, then sank by 90.72% to $1.9 million in 2023, then tumbled by 270.96% to -$3.2 million in 2024, then soared by 69.95% to -$967226.0 in 2025, then surged by 119.14% to $185096.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $185096.0, -$1.4 million, and -$967226.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -81.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | -912.40 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | -64.63 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 528.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 78.82 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 48.97 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 52.66 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 185,096.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185,096.00 |
| Mar 31, 2026 | -1.43 Mn |
| Dec 31, 2025 | -967,226.00 |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 466,265.00 |
| Mar 31, 2025 | 367,477.00 |
| Dec 31, 2024 | -3.22 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | -555,268.00 |
| Mar 31, 2024 | -3.08 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | -132,107.00 |
| Jun 30, 2023 | -9.87 Mn |
| Mar 31, 2023 | -8.59 Mn |
| Dec 31, 2022 | 20.30 Mn |
| Sep 30, 2022 | -432,626.00 |
| Jun 30, 2022 | -375,183.00 |
| Mar 31, 2022 | 664,388.00 |
| Dec 31, 2021 | -746,922.00 |
| Sep 30, 2021 | -102,669.00 |